The Marked Chart Wire · Health
Obesity Drugs
Zealand Pharma starts Phase 2 trial for obesity drug combo
Zealand Pharma announced the launch of its Phase 2 ZYNERGY study. The trial assesses the combined use of petrelintide and enicepatide in patients with obesity or overweight.
Part of a series: Obesity drug pipeline and access updates
